Title : Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.

Pub. Date : 2018 Nov

PMID : 30341696






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As consequence recent novel therapeutic drugs for neurodegenerative diseases has led to the development of multi target drugs, that possess selective brain MAO A and B inhibitory moiety, iron chelating and antioxidant activities and the ability to increase brain levels of endogenous neurotrophins, such as BDNF, GDNF VEGF and erythropoietin and induce mitochondrial biogenesis. Iron erythropoietin Homo sapiens